Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'POOR ANTICOAGULANT RESPONSE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 482 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sampram, ESK; Lindblad, B
      The impact of Factor V mutation on the risk for occlusion in patients undergoing peripheral vascular reconstructions

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    2. Dragoni, F; Tormene, D; Simioni, P; Arcieri, P; Avvisati, G; Girolami, A
      ProC global: A new automated screening assay for the evaluation of total function of the protein C system

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    3. Mira, Y; Todoli, J; Alonso, R; Mico, ML; Vaya, A; Ferrando, F; Estelles, A; Villa, P; Aznar, J
      Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: Two cases

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    4. Linfert, DR; Tsongalis, GJ
      Coexistence of the methylenetetrahydrofolate reductase single-nucleotide polymorphism (C677T) in patients with the factor V Leiden or prothrombin G20210A polymorphisms

      DIAGNOSTIC MOLECULAR PATHOLOGY
    5. Olah, L; Misz, M; Kappelmayer, J; Ajzner, E; Csepany, T; Fekete, I; Bereczki, D; Blasko, G; Csiba, L
      Natural coagulation inhibitor proteins in young patients with cerebral ischemia

      CEREBROVASCULAR DISEASES
    6. Quincampoix, JC; Legarff, M; Rittling, C; Andiva, S; Toulon, P
      Modification of the ProC (R) Global assay using dilution of patient plasmain factor V-depleted plasma as a screening assay for factor V Leiden mutation

      BLOOD COAGULATION & FIBRINOLYSIS
    7. Kayiran, SM; Ozbek, N; Caner, H; Tokel, KA; Mercan, S; Alehan, F
      Activated protein C resistance and false type 2 protein C deficiency detected after multiple shunt failures in a patient with hydrocephalus

      JOURNAL OF CHILD NEUROLOGY
    8. Incorvaia, C; Parmeggiani, F; Costagliola, C; Lamberti, G; Ferraresi, P; Bernardi, F; Sebastiani, A
      The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study

      GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    9. Robetorye, RS; Rodgers, GM
      Update on selected inherited venous thrombotic disorders

      AMERICAN JOURNAL OF HEMATOLOGY
    10. Emmerich, J; Rosendaal, FR; Cattaneo, M; Margaglione, M; De Stefano, V; Cumming, T; Arruda, V; Hillarp, A; Reny, JL
      Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including2310 cases and 3204 controls

      THROMBOSIS AND HAEMOSTASIS
    11. Martinelli, I
      Risk factors in venous thromboembolism

      THROMBOSIS AND HAEMOSTASIS
    12. Heit, JA; Silverstein, MD; Mohr, DN; Petterson, TM; Lohse, CM; O'Fallon, WM; Melton, LJ
      The epidemiology of venous thromboembolism in the community

      THROMBOSIS AND HAEMOSTASIS
    13. de Visser, MCH; Poort, SR; Vos, HL; Rosendaal, FR; Bertina, RM
      Factor X levels, polymorphisms in the promoter region of factor X, and therisk of venous thrombosis

      THROMBOSIS AND HAEMOSTASIS
    14. Shen, MC; Lin, JS; Tsay, W
      Factor V Arg(306)-> Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese

      THROMBOSIS AND HAEMOSTASIS
    15. Hoekema, L; Castoldi, E; Tans, G; Girelli, D; Gemmati, D; Bernardi, F; Rosing, J
      Functional properties of factor V and factor Va encoded by the R2-gene

      THROMBOSIS AND HAEMOSTASIS
    16. Rosing, J; Curvers, J; Tans, G
      Oral contraceptives, thrombosis and haemostasis

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    17. Bozzo, M; Carpani, G; Leo, L; Marcozzi, S; Sacchi, E; Moroni, G; Pardi, G
      HELLP syndrome and factor V Leiden

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    18. Linden, MD; Schneider, M; Erber, WN
      Factor V-LEIDEN and cardiopulmonary bypass: investigation of haemostatic parameters and the effect of aprotinin using an ex vivo model

      PERFUSION-UK
    19. Toulon, P; Adda, R; Perez, P
      Sensitivity of the ProC((R)) global assay for protein C pathway abnormalities. Clinical experience in 899 unselected patients with venous thromboembolism

      THROMBOSIS RESEARCH
    20. Nowak-Gottl, U; Kotthoff, S; Hagemeyer, E; Junker, R; Kehl, HG; Vielhaber, H; Kececioglu, D
      Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease - A prospective study

      THROMBOSIS RESEARCH
    21. Eldridge, J; Dilley, A; Austin, H; EL-Jamil, M; Wolstein, L; Doris, J; Hooper, WC; Meehan, PL; Evatt, B
      The role of protein C, protein S, and resistance to activated protein C inLegg-Perthes disease

      PEDIATRICS
    22. Hademenos, GJ; Alberts, MJ; Awad, I; Mayberg, M; Shephard, T; Jagoda, A; Latchaw, RE; Todd, HW; Viste, K; Starke, R; Girgus, MS; Walker, M; Marler, J; Emr, M; Hart, N
      Advances in the genetics of cerebrovascular disease and stroke

      NEUROLOGY
    23. Hoibraaten, E; Mowinckel, MC; de Ronde, H; Bertina, RM; Sandset, PM
      Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial

      BRITISH JOURNAL OF HAEMATOLOGY
    24. Walker, ID; Greaves, M; Preston, FE
      Investigation and management of heritable thrombophilia

      BRITISH JOURNAL OF HAEMATOLOGY
    25. Mannucci, PM
      Genetic hypercoagulability: prevention suggests testing family members

      BLOOD
    26. Federman, DG; Kirsner, RS
      An update on hypercoagulable disorders

      ARCHIVES OF INTERNAL MEDICINE
    27. Bauer, KA
      The thrombophilias: Well-defined risk factors with uncertain therapeutic implications

      ANNALS OF INTERNAL MEDICINE
    28. Gouin-Thibault, I; Achkar, A; Samama, MM
      The thrombophilic state in cancer patients

      ACTA HAEMATOLOGICA
    29. Spina, V; Aleandri, V; Morini, F
      The impact of the Factor V Leiden mutation on pregnancy

      HUMAN REPRODUCTION UPDATE
    30. Murphy, RP; Donoghue, C; Nallen, RJ; D'Mello, M; Regan, C; Whitehead, AS; Fitzgerald, DJ
      Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    31. Sartori, MT; Simioni, P; Patrassi, GM; Theodoridis, P; Tormene, D; Girolami, A
      Combined heterozygous plasminogen deficiency and factor V Leiden defect inthe same kindred

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    32. Bank, I; Middeldorp, S; Buller, HR
      Hereditary and acquired thrombophilia

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    33. Pecheniuk, NM; Walsh, TP; Marsh, NA
      DNA technology for the detection of common genetic variants that predispose to thrombophilia

      BLOOD COAGULATION & FIBRINOLYSIS
    34. Aillaud, MF; Morange, P; Juhan, I; Bauters, A; Jude, B; Biron-Andreani, C; Daures, JP; Schved, JF; Pernod, G; Polac, B; Bridey, F; De Prost, D; Borg, JY; Saladin-Theron, C; Le Cam, V; Denninger, MH; Truchaud, F; Trossaert, M; Boinot, C; Sultan, Y; Delahousse, B; Fimbel, B; Gruel, Y; Houbouyan, L; Bihour, C; Vergnes, C; Dutrillaux, F; Lorenzini, JL; Julia, A; Deschamps, A; Favier, R; Freyburger, G; Trzeciak, MC; Berruyer, M; Doumergue, G; Gris, JC; Toulon, P; Montpied, G; Marques-Verdier, A; Lequerrec, A; Guerin, V; Massignon, D
      Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotescarriers of the factor V Leiden mutation: retrospective analysis from the Procare Study

      BLOOD COAGULATION & FIBRINOLYSIS
    35. Pecheniuk, NM; Marsh, NA; Walsh, TP
      Multiple analysis of three common genetic alterations associated with thrombophilia

      BLOOD COAGULATION & FIBRINOLYSIS
    36. Yetkin, E; Erbay, AR; Ayaz, S; Ileri, M; Yanik, A; Yetkin, G; Cehreli, S; Goksel, S
      Predictors of left ventricular thrombus formation in patients with anterior myocardial infarction: role of activated protein C resistance

      CORONARY ARTERY DISEASE
    37. Mohanty, S; Saxena, R; Acharya, SK
      Activated protein C resistance in Budd-Chiari syndrome

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    38. Makris, TK; Krespi, PG; Hatzizacharias, AN; Gialeraki, AE; Anastasiadis, G; Triposkiadis, FK; Mandalaki, T; Kyriakidis, MK
      Resistance to activated protein C and FV Leiden mutation in patients with a history of acute myocardial infarction or primary hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    39. Deitcher, SR; Caiola, E; Jaffer, A
      Factor V Leiden and prothrombin G20210A - Demystifying two common genetic predispositions to venous thrombosis

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    40. Hingorani, A; Ascher, E; Yorkavich, W; Mazzariol, F; Jacob, T; Gunduz, Y; Salles-Cunha, S
      Upper extremity deep venous thrombosis: An underrecognized manifestation of a hypercoagulable state

      ANNALS OF VASCULAR SURGERY
    41. Silver, D; Vouyouka, A
      The caput medusae of hypercoagulability

      JOURNAL OF VASCULAR SURGERY
    42. Ioannou, HV; Mitsis, M; Eleftheriou, A; Matsagas, M; Nousias, V; Rigopoulos, C; Vartholomatos, G; Kappas, AM
      The prevalence of Factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece

      INTERNATIONAL ANGIOLOGY
    43. van Aken, BE; den Heijer, M; Bos, GMJ; van Deventer, SJH; Reitsma, PH
      Recurrent venous thrombosis and markers of inflammation

      THROMBOSIS AND HAEMOSTASIS
    44. de Visser, MCH; Guasch, JF; Kamphuisen, PW; Vos, HL; Rosendaal, FR; Bertina, RM
      The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis

      THROMBOSIS AND HAEMOSTASIS
    45. Luddington, R; Jackson, A; Pannerselvam, S; Brown, K; Baglin, T
      The factor V R2 allele: Risk of venous thromboembolism, factor V levels and resistance to activated protein C

      THROMBOSIS AND HAEMOSTASIS
    46. Kraus, JA; Stuper, BK; Nahser, HC; Klockgether, T; Berlit, P
      Significantly increased prevalence of factor V Leiden in patients with dural arteriovenous fistulas

      JOURNAL OF NEUROLOGY
    47. Marz, W; Nauck, M; Wieland, H
      The molecular mechanisms of inherited thrombophilia

      ZEITSCHRIFT FUR KARDIOLOGIE
    48. Pirisi-Hauck, NC; Foss, HD; Baier, J; Kurunczi, S
      Simultaneous occurrence of autoimmune enteropathy and recurrent deep venous thrombosis

      JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    49. Garcia-Doval, I; Losada, A; de la Torre, C; Gonzalez, A; Cruces, MJ
      Abdominal nodules as a presentation of obstruction of the inferior vena cava and factor V Leiden mutation

      JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    50. Dahlback, B
      Blood coagulation

      LANCET
    51. Arkel, YS
      Thrombosis and cancer

      SEMINARS IN ONCOLOGY
    52. Kostka, H; Siegert, G; Schwarz, T; Gehrisch, S; Kuhlisch, E; Schellong, S; Jaross, W
      Frequency of polymorphisms in the B-domain of factor V gene in APC-resistant patients

      THROMBOSIS RESEARCH
    53. Larsen, TB; Norgaard-Pedersen, B; Lundemose, JB; Rudiger, N; Gaustadnes, M; Brandslund, I
      Sudden infant death syndrome, childhood thrombosis, and presence of genetic risk factors for thrombosis

      THROMBOSIS RESEARCH
    54. Manucci, PM
      The molecular basis of inherited thrombophilia

      VOX SANGUINIS
    55. Ekberg, H; Svensson, PJ; Simanaitis, M; Dahlback, B
      Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection

      TRANSPLANTATION
    56. Gherman, RB; Goodwin, TM
      Obstetric implications of activated protein C resistance and factor V leiden Mutation

      OBSTETRICAL & GYNECOLOGICAL SURVEY
    57. Weih, M; Junge-Hulsing, J; Mehraein, S; Ziemer, S; Einhaupl, KM
      Hereditary thrombophilias in ischemic stroke and sinus vein thrombosis: diagnostic, therapy and meta-analysis

      NERVENARZT
    58. Walker, ID
      Thrombophilia in pregnancy

      JOURNAL OF CLINICAL PATHOLOGY
    59. Martinelli, I; Bucciarelli, P; Margaglione, M; De Stefano, V; Castaman, G; Mannucci, PM
      The risk of venous thromboembolism in family members with mutations in thegenes of factor V or prothrombin or both

      BRITISH JOURNAL OF HAEMATOLOGY
    60. Franco, RF; Middeldorp, S; Meinardi, JR; van Pampus, ECM; Reitsma, PH
      Factor XIII Va134Leu and the risk of venous thromboembolism in factor V Leiden carriers

      BRITISH JOURNAL OF HAEMATOLOGY
    61. Mitsis, M; Ioannou, H; Eleftheriou, A; Nousias, V; Basioukas, C; Kakosimos, G; Batsis, C; Vartholomatos, G
      Combined genetic defect (homogeneity for factor V Leiden and heterogeneityfor prothrombin G20210A allele), in a young patient, with recurrent deep vein thrombosis and serious postphlebitic syndrome - A case report

      ANGIOLOGY
    62. Hisar, I; Ileri, M; Yetkin, E; Atak, R; Senen, K; Kosar, F; Dundar, S; Demirkan, D
      Role of activated protein C resistance in left atrial thrombogenesis in patients with mitral stenosis

      ANGIOLOGY
    63. Major, DA; Sane, DC; Herrington, DM
      Cardiovascular implications of the factor V Leiden mutation

      AMERICAN HEART JOURNAL
    64. Schramm, W; Heinemann, LA; Spannagl, M; Dick, A; Assmann, A
      The Bavarian thromboembolie risk cohort study(BATER)

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    65. Simioni, P
      The molecular genetics of familial venous thrombosis

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    66. Bucciarelli, P; Rosendaal, FR; Tripodi, A; Mannucci, PM; De Stefano, V; Palareti, G; Finazzi, G; Baudo, F; Quintavalla, R
      Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance - A multicenter collaborative family study

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    67. Ehrenforth, S; Prondsinski, MV; Aygoren-Pursun, E; Scharrer, I; Ganser, A
      Study of the prothrombin gene 20201 GA variant in FV : Q(506) carriers in relationship to the presence or absence of juvenile venous thromboembolism

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    68. Junker, R; Koch, HG; Auberger, K; Munchow, N; Ehrenforth, S; Nowak-Gottl, U
      Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    69. Favaloro, EJ; Mirochnik, O; McDonald, D
      Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT- than APTT-based assays

      BRITISH JOURNAL OF BIOMEDICAL SCIENCE
    70. Provan, D; O'Shaughnessy, DF
      Recent advances in haematology

      BRITISH MEDICAL JOURNAL
    71. Mammo, L; Saour, JN
      Lack of association between factor V Leiden and thromboembolism in patients with prosthetic heart valves

      BLOOD COAGULATION & FIBRINOLYSIS
    72. Suzuki, S; Kobayashi, H; Matsuo, T
      Activated protein C ratio as a clue for protein S disorder in Japanese

      BLOOD COAGULATION & FIBRINOLYSIS
    73. de Ronde, H; Bertina, RM
      Careful selection of sample dilution and factor-V-deficient plasma makes the modified activated protein C resistance test highly specific for the factor V Leiden mutation

      BLOOD COAGULATION & FIBRINOLYSIS
    74. Hansson, PO; Eriksson, E; Welin, L; Eriksson, H
      Prevalence of APC resistance and its relationship to arterial and venous thromboembolism in a general population sample of elderly Swedish men: The Study of Men Born in 1913

      JOURNAL OF INTERNAL MEDICINE
    75. Faude, S; Faude, F; Siegemund, A; Wiedemann, P
      Activated protein C resistance in patients with central retinal vein occlusion in comparison to patients with a history of deep-vein thrombosis and ahealthy control group

      OPHTHALMOLOGE
    76. Loew, A; Riess, H
      Clinical importance and evidence of APC-resistance

      PHLEBOLOGIE
    77. Grohmann, G; Sigusch, HH; Reinhardt, D; Pohlmann, G; Hoffman, A; Figulla, HR
      Genetic risk factors for phlebothrombosis: New aspects under special consideration of the inherited resistance to activated protein C (coagulation factor V Leiden).

      PERFUSION
    78. Spencer, FA; Becker, RC
      Diagnosis and management of inherited and acquired thrombophilias

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    79. Koren, A; Zalman, L; Levin, C; Abu Hana, M; Mader, R; Shalev, S
      Venous thromboembolism, factor V Leiden, and methylenetetrahydrofolate reductase in a sickle cell anemia patient

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    80. Tirado, I; Mateo, J; Oliver, A; Borrell, M; Souto, JC; Fontcuberta, J
      Patients with venous thromboembolism have a lower APC response than controls. Should this be regarded as a continuous risk factor for venous thrombosis?

      HAEMATOLOGICA
    81. Zoller, B; de Frutos, PG; Hillarp, A; Dahlback, B
      Thrombophilia as a multigenic disease

      HAEMATOLOGICA
    82. Kuismanen, K; Savontaus, ML; Kozlov, A; Vuorio, AF; Sajantila, A
      Coagulation factor V Leiden mutation in sudden fatal pulmonary embolism and in a general northern European population sample

      FORENSIC SCIENCE INTERNATIONAL
    83. Happich, D; Schwaab, R; Hanfland, P; Hoernschemeyer, D
      Allelic discrimination of factor V Leiden using a 5 ' nuclease assay

      THROMBOSIS AND HAEMOSTASIS
    84. Bertina, RM
      Molecular risk factors for thrombosis

      THROMBOSIS AND HAEMOSTASIS
    85. Rosendaal, FR
      Risk factors for venous thrombotic disease

      THROMBOSIS AND HAEMOSTASIS
    86. Lindmarker, P; Schulman, S; Sten-Linder, M; Wiman, B; Egberg, N; Johnsson, H
      The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene

      THROMBOSIS AND HAEMOSTASIS
    87. McColl, MD; Chalmers, EA; Thomas, A; Sproul, A; Healey, C; Rafferty, I; McWilliam, R; Eunson, P
      Factor V Leiden, prothrombin 20210 G -> A and the MTHFR C677T mutations inchildhood stroke

      THROMBOSIS AND HAEMOSTASIS
    88. Mohanty, S; Saxena, R; Behari, M
      Activated protein C (APC) resistance in young stroke patients

      THROMBOSIS AND HAEMOSTASIS
    89. Alhenc-Gelas, M; Nicaud, V; Gandrille, S; van Dreden, P; Amiral, J; Aubry, ML; Fiessinger, JN; Emmerich, J; Aiach, M
      The factor V gene A4070G mutation and the risk of venous thrombosis

      THROMBOSIS AND HAEMOSTASIS
    90. Simioni, P; Sanson, BJ; Prandoni, P; Tormene, D; Friederich, PW; Girolami, B; Gavasso, S; Huisman, MV; Buller, HR; ten Cate, JW; Girolami, A; Prins, MH
      Incidence of venous thromboembolism in families with inherited thrombophilia

      THROMBOSIS AND HAEMOSTASIS
    91. Witham, TF; Nemoto, EM; Jungreis, CA; Kaufmann, AM
      Near-infrared spectroscopy monitored cerebral venous thrombolysis

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    92. Pablos, JL; Caliz, RA; Carreira, PE; Atsumi, T; Serrano, L; Amengual, O; Santiago, B; Khamashta, MA; Hughes, GRV; Gomez-Reino, JJ
      Risk of thrombosis in patients with antiphospholipid antibodies and factorV Leiden mutation

      JOURNAL OF RHEUMATOLOGY
    93. Samama, MM; Gerotziafas, G; Conrad, J; Horellou, MH; Elalamy, I
      Clinical aspects and laboratory problems in hereditary thrombophilia

      HAEMOSTASIS
    94. Rosendaal, FR
      Venous thrombosis: Prevalence and interaction of risk factors

      HAEMOSTASIS
    95. Coumans, ABC; Huijgens, PC; Jakobs, C; Schats, R; de Vries, JIP; van Pampus, MG; Dekker, GA
      Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion

      HUMAN REPRODUCTION
    96. Rosing, J; Middeldorp, S; Curvers, J; Thomassen, MCLGD; Nicolaes, GAF; Meijers, JCM; Bouma, BN; Buller, HR; Prins, MH; Tans, G
      Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

      LANCET
    97. Rasendaal, FR
      Venous thrombosis: a multicausal disease

      LANCET
    98. Sugimura, M; Kobayashi, T; Kanayama, N; Terao, T
      Detection of decreased response to activated protein C during pregnancy byan endogenous thrombin potential-based assay

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    99. Baker, WF; Bick, RL
      Treatment of hereditary and acquired thrombophilic disorders

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    100. Dahlback, B
      Activated protein C resistance and thrombosis: Molecular mechanisms of hypercoagulable state due to FVR506Q mutation

      SEMINARS IN THROMBOSIS AND HEMOSTASIS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/01/21 alle ore 21:18:57